Inogen Appoints Vafa Jamali to Board

Medical device company adds new director with industry experience.

Apr. 6, 2026 at 9:38pm

A photorealistic studio still-life image of a sleek, modern medical device made of polished metal and glass, floating on a clean white background with dramatic lighting and shadows, symbolizing Inogen's innovative technology and industry leadership.Inogen's new board appointment signals the company's focus on strategic growth in the portable oxygen market.Beverly Today

Inogen, a leading manufacturer of portable oxygen concentrators, has announced the appointment of Vafa Jamali to its board of directors. Jamali brings extensive experience in the medical device industry, having previously held leadership roles at several prominent healthcare companies.

Why it matters

Inogen's board appointments are closely watched as the company navigates the competitive portable oxygen market. Jamali's addition signals the company's focus on strengthening its leadership and strategic direction as it continues to innovate and grow its business.

The details

Vafa Jamali most recently served as the Chief Commercial Officer at Intuitive Surgical, a pioneer in robotic-assisted surgery. Prior to that, he held senior roles at Medtronic and Johnson & Johnson. Jamali's deep industry expertise is expected to provide valuable guidance to Inogen as it looks to expand its product portfolio and global footprint.

  • Inogen announced Jamali's appointment on April 6, 2026.

The players

Inogen

A leading manufacturer of portable oxygen concentrators.

Vafa Jamali

An experienced medical device executive who has been appointed to Inogen's board of directors.

Got photos? Submit your photos here. ›

What they’re saying

“We are thrilled to welcome Vafa to the Inogen board. His deep expertise in the medical device industry and track record of driving growth will be invaluable as we continue to expand our business.”

— Scott Wilkinson, CEO, Inogen

The takeaway

Inogen's addition of Vafa Jamali to its board signals the company's commitment to strengthening its leadership and strategic direction as it navigates the competitive portable oxygen market.